Risk factors affecting the clinical course of COVID-19 in patients with lymphoid malignancies in the Omicron subvariants era – a real-world analysis by the Polish Adult Lukemia Study Group

Agnieszka Szymczyk; Antonina Dytfeld; Katarzyna Brzeźniakiewicz‐Janus; Ewa Wąsik‐Szczepanek; Elżbieta Kalicińska; Bartosz Puła; Anna Kopińska; Joanna Drozd‐Sokołowska; Iwona Hus

doi:10.26444/aaem/208957

September 3, 2025Annals of Agricultural and Environmental MedicineOpen Access

Risk factors affecting the clinical course of COVID-19 in patients with lymphoid malignancies in the Omicron subvariants era – a real-world analysis by the Polish Adult Lukemia Study Group

View Full Paper

Ask AI

Bookmark

Share

Key Points

Patients with lymphoid malignancies face higher risks during COVID-19, especially with omicron subvariants.
The analysis highlights critical factors affecting the clinical course, including treatment modifications.
Real-world data from the Polish Adult Leukemia Study Group reveal significant implications for patient management.
Understanding these risks can help guide therapeutic strategies and improve outcomes for affected patients.

Implication

Real-world analysis examines the clinical course of COVID-19 in lymphoid malignancy patients, suggesting tailored treatment strategies.

Abstract

Guo W, Zheng Y, Feng S. Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes. Front Cell Infect Microbiol. 2023 Oct 19;13:1207225. CrossRef Google Scholar

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Szymczyk et al. (2025) studied this question.

synapsesocial.com/papers/68c1872d9b7b07f3a06116a3 https://doi.org/10.26444/aaem/208957

View Full Paper

Ask AI

Bookmark

Share

Risk factors affecting the clinical course of COVID-19 in patients with lymphoid malignancies in the Omicron subvariants era – a real-world analysis by the Polish Adult Lukemia Study Group

Key Points

Implication

Abstract

Discussion

Cite This Study

Risk factors affecting the clinical course of COVID-19 in patients with lymphoid malignancies in the Omicron subvariants era – a real-world analysis by the Polish Adult Lukemia Study Group

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from Annals of Agricultural and Environmental Medicine

Keep reading

More related papers

More from Annals of Agricultural and Environmental Medicine